Ariad Pharmaceuticals Inc Sample Contracts

AutoNDA by SimpleDocs
EXECUTION COPY
Loan and Security Agreement • March 22nd, 2002 • Ariad Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Massachusetts
MARCH 4, 1997 2 JOINT VENTURE MASTER AGREEMENT
Operating Agreement • May 13th, 1997 • Ariad Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Delaware
EXHIBIT 10.14
Agreement • March 10th, 1998 • Ariad Pharmaceuticals Inc • Biological products, (no disgnostic substances) • California
RECITALS
Loan and Security Agreement • November 14th, 2002 • Ariad Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Massachusetts
AND
Common Stock Purchase Agreement • July 7th, 2000 • Ariad Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Delaware
RODMAN & RENSHAW, INC. 1250 Broadway, 14th Floor New York, NY 10001 212-356-0500 Fax 212-760-1080
Letter Agreement • May 19th, 2003 • Ariad Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York

In consideration of the services rendered by Rodman under this Agreement, the Company agrees to pay Rodman a cash fee payable immediately upon the closing of any portion of any Financing equal to 5.5% of the aggregate capital raised at such closing; provided, however, that no cash fee shall be due from the Company to Rodman under the Letter Agreement between the Company and Rodman dated as of November 7, 2002, which is superseded and supplanted by this Agreement. The Company will also pay to Rodman up to an aggregate of $25,000 to reimburse Rodman for its out-of-pocket expenses related to the Financing.

ARIAD PHARMACEUTICALS, INC. 15,307,000 Shares of Common Stock, par value $0.001 per share Underwriting Agreement
Ariad Pharmaceuticals Inc • January 24th, 2013 • Biological products, (no disgnostic substances) • New York
COMMON STOCK
Ariad Pharmaceuticals Inc • October 20th, 2006 • Biological products, (no disgnostic substances) • New York
AutoNDA by SimpleDocs
and
Rights Agreement • June 19th, 2000 • Ariad Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Delaware
LICENSE AGREEMENT
License Agreement • November 12th, 1997 • Ariad Pharmaceuticals Inc • Biological products, (no disgnostic substances) • Massachusetts
EXHIBIT 10.60 ARIAD GENE THERAPEUTICS, INC. STOCK TRANSFER AGREEMENT In consideration of the covenants and agreements set forth herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby mutually...
Transfer Agreement • March 2nd, 2004 • Ariad Pharmaceuticals Inc • Biological products, (no disgnostic substances)

In consideration of the covenants and agreements set forth herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby mutually acknowledged, the parties hereto covenant and agree as follows:

7,500,000 Shares ARIAD PHARMACEUTICALS, INC. Common Stock UNDERWRITING AGREEMENT
Underwriting Agreement • August 5th, 2005 • Ariad Pharmaceuticals Inc • Biological products, (no disgnostic substances) • New York

As Representatives of the several underwriters named in Schedule 1 hereto c/o Lehman Brothers Inc. 745 Seventh Avenue New York, New York 10019

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!